610 related articles for article (PubMed ID: 16020270)
21. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
22. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system.
Arai M; Sasaki A; Saito N; Nakazato Y
Pathol Int; 2005 Mar; 55(3):122-9. PubMed ID: 15743320
[TBL] [Abstract][Full Text] [Related]
24. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
25. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
Heidenkummer HP; Kampik A
Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
[TBL] [Abstract][Full Text] [Related]
26. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide mediates dendritic cell apoptosis by downregulating inhibitors of apoptosis proteins and upregulating effector caspase activity.
Stanford A; Chen Y; Zhang XR; Hoffman R; Zamora R; Ford HR
Surgery; 2001 Aug; 130(2):326-32. PubMed ID: 11490367
[TBL] [Abstract][Full Text] [Related]
28. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment.
Kuo YR; Wu WS; Jeng SF; Huang HC; Yang KD; Sacks JM; Wang FS
Lasers Surg Med; 2005 Jan; 36(1):31-7. PubMed ID: 15662632
[TBL] [Abstract][Full Text] [Related]
29. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.
Zhao F; Gandorfer A; Haritoglou C; Scheler R; Schaumberger MM; Kampik A; Schumann RG
Retina; 2013 Jan; 33(1):77-88. PubMed ID: 22914684
[TBL] [Abstract][Full Text] [Related]
30. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
[TBL] [Abstract][Full Text] [Related]
31. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
32. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure.
de Boer RA; van Veldhuisen DJ; van der Wijk J; Brouwer RM; de Jonge N; Cole GM; Suurmeijer AJ
J Card Fail; 2000 Dec; 6(4):330-7. PubMed ID: 11145758
[TBL] [Abstract][Full Text] [Related]
33. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
34. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Vinores SA; Campochiaro PA; Conway BP
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):14-28. PubMed ID: 1688833
[TBL] [Abstract][Full Text] [Related]
36. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
Heidenkummer HP; Kampik A
Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
[TBL] [Abstract][Full Text] [Related]
37. [Vitreous surgery with trypan blue staining of membranes in PVR retinal detachment surgery].
Nawrocki J; Michalewska Z; Michalewski J
Klin Monbl Augenheilkd; 2005 Jul; 222(7):572-6. PubMed ID: 16034725
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic cell death in proliferative vitreoretinopathy.
Esser P; Bartz-Schmidt KU; Walter P; Kaszli F; Heimann K; Weller M
Ger J Ophthalmol; 1996 Mar; 5(2):73-8. PubMed ID: 8741150
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis.
Jeruc J; Vizjak A; Rozman B; Ferluga D
Am J Kidney Dis; 2006 Sep; 48(3):410-8. PubMed ID: 16931214
[TBL] [Abstract][Full Text] [Related]
40. [Retinal shortening: the most severe form of proliferative vitreoretinopathy (PVR)].
Pastor JC; Rodríguez de la Rúa E; Martín F; Mayo-Iscar A; de la Fuente MA; Coco R; Bailez C; Mahave S
Arch Soc Esp Oftalmol; 2003 Dec; 78(12):653-7. PubMed ID: 14689321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
